Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | GFER | P55789 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6295282 | 0.91 | USP2 (0.66) | SIGMAR1ALDH1A1MAPK1GFERSMN1; SMN2 | |
| SCHEMBL7011356 | 0.89 | USP2 (0.60) | SIGMAR1ALDH1A1MAPK1GFERSMN1; SMN2 | |
| SCHEMBL7506700 | 0.84 | SIGMAR1 (0.50) | SIGMAR1ALDH1A1MAPK1GFERSMN1; SMN2 | |
| SCHEMBL3971066 | 0.83 | TSHR (0.66) | SIGMAR1ALDH1A1KMT2ANEK1 | |
| SCHEMBL3712996 | 0.83 | SIGMAR1 (0.73) | SIGMAR1ALDH1A1MAPK1GFERSMN1; SMN2 | |
| SCHEMBL6034681 | 0.82 | SIGMAR1 (1.00) | SIGMAR1ALDH1A1MAPK1GFERSMN1; SMN2 | |
| SCHEMBL7014515 | 0.81 | CA12 (0.62) | SIGMAR1ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL1674212 | 0.81 | SIGMAR1 (0.74) | SIGMAR1ALDH1A1MAPK1GFERSMN1; SMN2 | |
| SCHEMBL3324949 | 0.81 | SIGMAR1 (0.74) | SIGMAR1ALDH1A1MAPK1GFERSMN1; SMN2 | |
| SCHEMBL9510691 | 0.81 | SIGMAR1 (1.00) | SIGMAR1ALDH1A1MAPK1GFERSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7495040-B2 | Actinic ray curable composition, image forming method using the same and ink-jet recording apparatus using the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-02-24 | — | — | US | disclosed |
| US-20080012918-A1 | Actinic Radiation Curable Ink-Jet Ink, And Image Forming Method And Ink-Jet Recording Apparatus Using The Same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20050196697-A1 | Actinic ray curable composition, image forming method using the same and ink-jet recording apparatus using the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2005-09-08 | — | — | US | disclosed |
| US-20050165123-A1 | Actinic ray curable composition, image forming method using the same and ink-jet recording apparatus using the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2005-07-28 | — | — | US | disclosed |
| US-6855719-B1 | Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives | ASTRAZENECA AB (SE) | 2005-02-15 | — | — | US | disclosed |
| CN-1174981-C | Imidazo [1, 2-A ] pyridine and pyrazolo [2, 3-A ] pyridine derivatives | — | 2004-11-10 | — | — | CN | disclosed |
| EP-1214318-B1 | IMIDAZO[1,2-A]PYRIDINE AND PYRAZOLO[2,3-A]PYRIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2003-10-08 | — | — | EP | disclosed |
| CN-1370163-A | Imidazo [1,2-A] pyridine and pyrazolo [2,3-a] pyridine derivatives | ASTRAZENECA AB (SE) | 2002-09-18 | — | — | CN | disclosed |
| EP-1214318-A1 | IMIDAZO[1,2-A]PYRIDINE AND PYRAZOLO[2,3-A]PYRIDINE DERIVATIVES | AstraZeneca AB (SE) | 2002-06-19 | — | — | EP | disclosed |
| WO-2001014375-A1 | IMIDAZO[1,2-A]PYRIDINE AND PYRAZOLO[2,3-A]PYRIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-03-01 | — | — | WO | disclosed |